Correction of hemostasis and hemorheology with intravenous laser blood irradiation and cytokinotherapy in indirect revascularization at the perioperative period in patients with critical ischemia of their lower extremities

Purpose. To study potentials for correcting hemostasis and hemorheology with intravenous laser blood irradiation (ILBI) and cytokine therapy (CT) in indirect revascularization at the perioperative period in patients with critical ischemia of lower extremities. Material and methods. A prospective controlled clinical trial included 162 patients with critical lower limb ischemia (CLLI) having distal arterial steno-occlusion who had indirect revascularization surgery. CLLI etiological factors were: obliterating atherosclerosis in 108 (66.7%) patients and obliterating thromboangiitis in 54 (33.3%) patients. 56 patients had chronic ischemia of degree III; 106 patients – chronic ischemia of degree IV. All patients were divided into 5 groups who had various curative modalities at their perioperative period: Group I (n = 34) –standard treatment; Group II (n = 32) – standard treatment + ILBI; Group III (n = 32) – standard treatment + CT with Roncoleukin; Group IV (n = 33) – standard treatment + ILBI + CT; patients from Group V (n = 31) in revascularizing osteotrepanation had intraosseous marrow laser irradiation (IOLI) – standard treatment + ILBI + CT. The researchers also studied dynamics of hemostatic parameters (fibrinogen – F, fibrinolytic activity – FA, fibrin degradation products – PDF, activity of antithrombin-III, plasminogen – P) and hemorheology (erythrocyte deformability – DE, von Willebrand factor – WF, ADP induced platelet aggregation). The obtained hemostasis and hemorheology findings were compared with identical parameters of 48 practically healthy subjects («reference group»). Results. On admission, patients with CLLI in distal steno-occlusion had a sharp change in their hemostasis formula shifting towards hypercoagulation and deterioration of hemorheology. ILBI and CT techniques applied either separately or in combination with other therapeutic measures in the perioperative period of indirect revascularization normalized parameters of blood coagulation system (for all parameters – p < 0.05; r = 0.4) and of hemorheology (for DE – p < 0.05; r = 0.4; for WF and ADP-induced platelet aggregation – p < 0.05; r = 0.3). The best results were obtained under the combination of ILBI and CT at the perioperative period of indirect revascularization, especially in revascularizing osteotrepanation with IOLI. Conclusion. ILBI and CT applied in combination with standard treatment at the perioperative period in indirect revascularization reliably correct hemostasis and hemorheology in patients with CLLI and distal arterial steno-occlusion.

critical lower limb ischemia, indirect revascularization, intravenous laser blood irradiation, intraosseous laser irradiation, cytokinotherapy, hemostasis, hemorheology

1. Drozhzhin E.V., Katelnitsky I.I., Nikitina Yu.V. et al. Features of hemocoagulation disorders in patients with critical ischemia of lower extremities and diabetes mellitus. Vestnik Natsional'nogo mediko-khirurgicheskogo Tsentra im. N.I. Pirogova. 2018; 13 (1): 49–52. [In Russ.].

2. Drozhzhin E.V., Sidorkina O.N., Nikitina Yu.B., Fedorov D.A. Dynamics of changes in the fibrinolytic systems of hemostasis in patients with critical ischemia of lower extremities. Scientific journal Modern problems of science and education. 2012; 6. URL: http://www.science-education.ru/ru/article/view?id=7447. [In Russ.].

3. Kazantsev A.V., Korymasov E.A. Obliterating atherosclerosis of vessels in lower extremities: diagnosing in progressing course of the disease. Kubanskiy nauchnyy vestnik. 2010; (8): 88–92. [In Russ.].

4. Petukhov E.B., Kuznetsov M.R., Fedin A.I. et al. Hemorheologic problems in chronic arterial insufficiency of the lower extremities. Angiologiya i sosudistaya terapiya. 2009; 15 (2): 13–18. [In Russ.].

5. Sukovatykh B.S., Knyazev V.V. Predicting the development of critical ischemia in patients with chronic obliterating arterial disease in lower extremities. Khirurgiya. 2008; 3: 45–49. [In Russ.].

6. Abushov N.S., Zakirjayev E.J., Tagizade G.T. et al. Dinamics of hemostasis parametres in patients with thrombangiitis obliterans and critical lower limb ischemia at application of ozonized autohemotransfusion. 21 st Eurochap of International Union National Congress of SIDV, Rome, September 28 October 1. Intertational Angiology, 2013; 31: 20.

7. Kuznetsov M.R., Koshkin V.M., Karalkin A.V. Early reocclusion in patients with obliterating atherosclerosis. Edited by V.S. Savelyev. Yaroslavl: Nuance. 2007: 175. [In Russ.].

8. Lazarenko V.A., Bobrovskaya E.A., Khruslov M.V. Evaluation of fibrinolytic activity in patients with obliterating atherosclerosis of the lower extremities before and after reconstructive interventions. Tromboz, gemomtaz i reologiya. 2017; 1 (69): 55–59. [In Russ.].

9. Lazarenko V.A., Bobrovskaya E.A., Belshkov L.N. Dynamics of the lipid profile and hemorelogy in patients with obliterating atherosclerosis of arteries in lower extremities at pre- and postoperative periods. Arkhiv vnutrenney meditsiny. 2019; 9 (3): 206–212. DOI: 10.20514/2226-6704-2019-9-3-206-212. [In Russ.].

10. National guidelines for the diagnosis and treatment of diseases of arteries of the lower extremities. Angiologiya i sosudistaya khirurgiya (Appendix No 2). 2019; 25 (2): 110. [In Russ.].

11. Agaev B.A., Kosaev J.V., Namazov I.L., Budagov I.K. Possibilities of non-medicamentous correction of hemostasis and gamorheology before and after reconstructive surgery in patients with critical ischemia of the lower extremities. Lazernaya Medicina. 2014; 18 (4): 13. [In Russ.].

12. Kosaev J.V., Rakhmani S.A., Namazov I.L., Budagov I.K. Non-medicamentous correction of lipid metabolism and hemorheology in patients with obliterating atherosclerosis and critical ischemia of the lower extremities. Vestnik khirurgii Kazakhstana. 2013 (4): 11–13. [In Russ.].

13. Svetlikov A.V., Sapelkin S.V., Ishpulaeva L.E., Gorbunov G.N. Anti-thrombotic therapy in patients with peripheral arterial disease. Angiologiya i sosudistaya khirurgiya. 2018; 24 (3): 13–17. [In Russ.].

14. Hiat W.R., Fowkes F.G., Heizer G. Ticagrelor versus clopidogrel in symtomatic peripheral artery disease. N. Engl. J. med. 2017; 37 (1): 32–40.

15. Hussain M.A., Al-Omran M., Creager M.A. Antithrombotic Therapy for periferal Artery Disease: Recent Advances. J. Av. Coll. Cardiol. 2018; 78 (21): 2450–2467.

16. Kosaev J.V. Effects of revascularizing osteotrepanation, cytokine therapy and laser irradiation on the clinical course of critical lower limb ischemia. XIII Annual session of the Bakulev Scientific Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences with the All-Russian Conference of Young Scientists: Moscow, May 17–19, 2009. Byulleten NTSSSKH im.A.N.Bakuleva RAMN: Serdechno–sosudistyye zabolevaniya (Appendix). 2009; 10 (3): 83. [In Russ.].

17. Kosaev J.V. Changes in the von Willebrand factor and circulating immune complex in patients with critical lower limb ischemia and their correction by cytokine therapy and intraosseous laser irradiation. The XII Annual session of Bakulev Scientific Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences with the All-Russian Conference of Young Scientists: Moscow, 18–20 May 2008. Byulleten NTSSSKH im.A.N.Bakuleva RAMN: Serdechno–sosudistyye zabolevaniya (Appendix). 2008; 9 (3): 94. [In Russ.].

18. Kosaev D.V., Abyshov N.S., Tagizade G.T., Rakhmani S.A. The effect of cytokine therapy and intraosseous laser irradiation on mediators of the systemic inflammatory response in patients with critical ischemia of the lower extremities. XII Annual session of the Bakulev Scientific Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences with the All-Russian Conference of Young Scientists: Moscow, May 18–20, 2008. Byulleten NTSSSKH im.A.N.Bakuleva RAMN: Serdechno–sosudistyye zabolevaniya (Appendix). 2008; 9 (3): 95. [In Russ.].

19. Grzhibovsky A.M. Correlation analysis. Ekologiya cheloveka. 2008 (9): 50–60. [In Russ.].

20. Cassar K., Bachoo P., Ford I. et al. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg. 2005; 29 (2): 171–176. DOI:10.1016/j.ejvs.2004.11.001

21. Kalinin R.E., Suchov I.A., Mzhavanadze N.D. et al. Intrinsic coagulation cascade factors and hemostatic markers of endothelial dysfunction in patients with peripheral artery disease. Novosti Khirurgii. 2018; 26 (5): 547–554.

22. Rayt H.S., Merker L., Davies R.S. Coagulation, Fibrinolysis and Platelet Activation Following Open Surgical or Percutaneus Angioplasty Revascularization for Symptomatic Lower Limb Chronic ischemia. Vasc. Endovascular. Surg. 2015; 50, (3): 193–201. DOI: 10.1177/1538574416638759.

23. Vischer U.M. Von Willibrand factor, endothelial dysfunction and cardiovascular disease. J. Thromb. Haemost. 2006; 4 (6): 1186–1193. DOI: 10.11/j.1538-7836.2006.01949.x